Abstract
A series of novel N-phenylpyrazole containing acyl derivatives 3a, b, N-methylimidiazole 4, thiazole derivatives 6a-d, benzimidiazole derivatives 7a-c pyrane and pyridine 8, 9a, b, tetrazole 10, pyridodipyrimidine 11, and dihydronaphthaline derivatives 15 have been synthesized. The structure of the newly synthesized compounds was elucidated by IR, 1H NMR, 13C NMR, Mass spectra and Elemental analysis. The newly synthesized compounds were evaluated for their antitumor activity against three tumor cell lines, liver cancer (HepG2), human colonic carcinoma cell line (HCT-116), and human breast adenocarcinoma (MCF-7). Compounds 6d, 7b, c, 9b and 11 exhibited higher antitumor activity compared with the reference drug Doxorubicin.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
